STOCK TITAN

BARK, Inc. (NYSE: BARK) hires Anya Hamill as CFO with robust severance

(High)
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

BARK, Inc. appointed Anya Hamill as Chief Financial Officer, effective September 8, 2026. Her compensation includes a $450,000 base salary, an annual target bonus of 75% of base salary (generally 50% cash and 50% stock), and a guaranteed nine‑month bonus for fiscal 2027 with a different cash/stock mix.

Hamill will receive 37,500 restricted stock units and 37,500 stock options under the 2021 Equity Incentive Plan, vesting over four years, plus a $100,000 sign‑on bonus paid in two installments. A Severance and Change in Control Agreement provides up to 12 months salary and partial equity acceleration upon an Involuntary Termination, and enhanced benefits—two times base salary plus target bonus, full time‑based equity vesting and up to 24 months COBRA coverage—if such termination occurs in connection with a Change in Control. Interim CFO Brian Dostie will resign from the interim CFO role on September 8, 2026 and continue as Vice President, Accounting and Controller.

Positive

  • None.

Negative

  • None.

Filing Explained

The CFO appointment is future-dated, while execution of the attached severance agreement is not shown and its benefits remain conditional.

BARK reports a Chief Financial Officer appointment effective September 8, 2026; the related compensation and severance terms describe future company obligations, not payments shown as made in this filing.

The filing says Hamill will enter the severance agreement, but the attached agreement has a blank effective date and signature fields, so its execution is not shown in this filing.

Any severance under the agreement requires an involuntary termination, return of company property, and a signed, unrevoked release; the benefits can also be denied after specified willful financial misconduct.

The agreement's change-in-control protections apply only to an involuntary termination during the period beginning six months before and ending eighteen months after a change in control.

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
CFO base salary $450,000 Annual base salary for Anya Hamill as Chief Financial Officer
Target bonus rate 75% of base salary Annual target bonus opportunity for the CFO role
Initial RSU grant 37,500 restricted stock units Equity award under the 2021 Equity Incentive Plan
Initial option grant 37,500 options Stock options to purchase common stock under the 2021 Equity Incentive Plan
Sign-on bonus $100,000 One-time bonus paid 50% at start and 50% at first quarterly anniversary
Standard severance period 12 months Base-salary continuation and COBRA coverage after Involuntary Termination
CIC severance multiple 2 times base salary plus target bonus Cash severance if Involuntary Termination occurs in Change in Control window
Change in Control voting threshold more than 50% Beneficial ownership of total voting power triggering Change in Control definition
Involuntary Termination regulatory
"If you are subject to an Involuntary Termination, then you will be entitled"
Change in Control regulatory
"In the event you are subject to an Involuntary Termination in the six (6) months prior to a Change in Control"
A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.
COBRA regulatory
"continued health insurance coverage under the Consolidated Omnibus Budget Reconciliation Act (“COBRA”)"
COBRA is a U.S. federal law that lets employees and their dependents temporarily keep employer-sponsored health insurance after job loss, reduction in hours, or other qualifying events by paying the premiums themselves. Investors should care because offering COBRA can affect a company’s cash flow, administrative costs and legal disclosures when workforce changes occur—similar to a former club member paying to keep their membership active after leaving the club.
Section 409A regulatory
"a “separation from service,” as defined in the regulations under Section 409A of the Code"
parachute payment financial
"would constitute a “parachute payment” within the meaning of Section 280G of the Code"
Resignation for Good Reason regulatory
"The term “Resignation for Good Reason” means a Separation as a result of the Executive’s resignation"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What executive leadership change did BARK (BARK) announce in this 8-K?

BARK appointed Anya Hamill as Chief Financial Officer, effective September 8, 2026. She will report to Co-Founder, Executive Chairman, and CEO Matt Meeker, while Brian Dostie steps down as Interim CFO and continues as Vice President, Accounting and Controller.

What is the compensation package for BARK (BARK)’s new CFO Anya Hamill?

Anya Hamill will receive a $450,000 base salary and an annual target bonus of 75% of base salary, typically paid 50% in cash and 50% in stock. She also has a guaranteed nine‑month bonus for fiscal 2027 with a different cash/stock mix and a $100,000 sign‑on bonus.

What equity awards will BARK (BARK)’s new CFO receive?

Hamill will receive an initial grant of 37,500 restricted stock units and 37,500 stock options under BARK’s 2021 Equity Incentive Plan. 25% vests on September 10, 2027, with the remainder vesting quarterly over twelve quarters, subject to continued employment.

What severance protections does BARK (BARK) provide to its new CFO?

If subject to an Involuntary Termination, Hamill is eligible for 12 months of base-salary continuation, a lump-sum pro-rated target bonus, 12 months accelerated vesting of time-based equity, and 12 months COBRA coverage, subject to signing a release and other conditions.

How does a Change in Control affect Anya Hamill’s severance at BARK (BARK)?

If an Involuntary Termination occurs within six months before, on, or within 18 months after a Change in Control, Hamill is entitled to a lump sum of 2x base salary plus target bonus, full vesting of time-based equity, and up to 24 months COBRA coverage.

What is the sign-on bonus structure for BARK (BARK)’s new CFO?

Hamill will receive a $100,000 one-time sign-on bonus, with 50% payable at the start of her employment and 50% on the first quarterly anniversary of her start date, in each case conditioned on continued employment with BARK.
0001819574FALSE00018195742026-07-282026-07-280001819574bark:CommonStockPareValue00001Member2026-07-282026-07-28

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date Earliest Event Reported):
July 28, 2026
 
BARK, Inc.
(Exact name of registrant as specified in its charter)
 
Delaware 001-39691 85-1872418
(State or Other Jurisdiction
of Incorporation)
 (Commission File Number) (IRS Employer Identification No.)
20 Jay Street, Suite 940
Brooklyn, NY
 
11201
(Zip Code)
(Address of Principal Executive Offices) 
(855) 501-2275
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e- 4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class 
Trading
Symbol(s)
 
Name of each exchange on
which registered
Common Stock, par value $0.0001 BARK New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐



Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Appointment of Officer

On July 28, 2026, BARK, Inc. (the “Company”) announced that Anya Hamill will join as Chief Financial Officer of the Company, effective September 8, 2026.

Ms. Hamill, age 52, most recently served as CFO of Laird Superfood, a plant-based food and beverage company, from 2022 until joining BARK, after serving as the CFO of Little Secrets Chocolates, a gourmet chocolate snacks and candies company, since 2018. Previously, Hamill held senior level financial roles at other leading CPG companies including Danone North America and Whitewave Foods, where she was successful in supporting and delivering ambitious growth agendas for premium brands.

Ms. Hamill's offer letter with the Company (the “Offer Letter”) provides for an annual compensation package consisting of a base salary of $450,000 and an annual target bonus opportunity of 75% of base salary payable 50% in cash and 50% in immediately vested and unrestricted shares of the Company, with a guaranteed nine (9) month bonus for fiscal year 2027 payable 75% in cash and 25% in immediately vested and unrestricted shares of the Company. Ms. Hamill will also receive an initial grant of 37,500 restricted stock units and 37,500 options to purchase common stock of the Company under the Company’s 2021 Equity Incentive Plan, of which 25% will vest September 10, 2027 and the balance will vest quarterly over twelve quarters in substantially equal amounts, subject to Ms. Hamill’s continued employment. In addition, the Offer Letter provides for a one-time sign-on bonus in the amount of $100,000, 50% payable upon the commencement of Ms. Hamill's employment with the Company and 50% payable on the first quarterly anniversary Ms. Hamill's employment with the Company, subject to Ms. Hamill’s continued employment.

Ms. Hamill will enter into the Company’s Indemnity Agreement in the same form entered into by the Company’s other executive officers. She will also enter into a Severance and Change in Control Agreement that provides (i) upon an involuntary termination for (a) salary continuation payments equal to twelve (12) months base salary, (b) a lump sum payment equal to the pro-rated target annual bonus for the relevant fiscal year, (c) twelve (12) months accelerated vesting of time-based equity awards, and (d) twelve (12) months continued health insurance coverage under the Consolidated Omnibus Budget Reconciliation Act (“COBRA”); and (ii) upon an involuntary termination occurring six (6) months prior to, or eighteen (18) months after, a change in control of the Company for (x) a lump sum payment equal to two (2) times annual base salary plus Ms. Hamill's target annual bonus, (y) accelerated vesting of all time-based equity awards, and (z) twenty four (24) months continued health insurance coverage under COBRA.

There is no arrangement or understanding between Ms. Hamill and any other persons pursuant to which Ms. Hamill was selected as Chief Financial Officer of the Company. Furthermore, there are no transactions between Ms. Hamill and the Company that would be required to be reported under Item 404(a) of Regulation S-K. Finally, no family relationships exist between Ms. Hamill and any of the Company’s directors or executive officers.

Resignation of Officer

On September 8, 2026, Brian Dostie will resign as Interim Chief Financial Officer of the Company effective. Mr. Dostice will remain as Vice President, Accounting and Controller.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits




Exhibit No.Description
99.1
Press release dated July 28, 2026
99.2
Severance and Change in Control Agreement
104Cover Page Interactive Data File (embedded within the Inline XBRL document)

 




SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 

BARK, Inc.
By:/s/ Allison Koehler
Name: Allison Koehler
Title: Chief Legal Officer and Secretary
Date: July 28, 2026


image_0.jpg

BARK APPOINTS ANYA HAMILL AS CHIEF FINANCIAL OFFICER

Hamill Brings Over 20 Years of Financial Leadership Experience Across
Public Companies and Direct-to-Consumer CPG Brands

NEW YORK, July 28, 2026 – BARK, Inc. (“BARK” or the “Company”) (NYSE: BARK), a leading global omnichannel brand with a mission to make all dogs happy, today announced that Anya Hamill will join the Company as Chief Financial Officer, effective September 8, 2026.

Ms. Hamill possesses more than 20 years of strategic finance experience in public consumer packaged goods companies (“CPG”) and private equity-backed emerging companies, and brings expertise in the natural food and beverage space. She most recently served as CFO of Laird Superfood from 2022 to 2026 where she led the accounting and finance organization, including financial planning and analysis, SEC reporting, treasury, investor relations, capital markets and M&A and internal controls. During her tenure, she helped improve profitability and cash flow, led significant operational and financial transformation initiatives, strengthened financial reporting processes, and partnered closely with the executive leadership team and the board of directors on strategic initiatives, acquisitions, and capital allocation.

From 2018 to 2022, Ms. Hamill served as the CFO of Little Secrets Chocolates, where she oversaw finance, accounting, human resources, information technology, and legal functions. During her tenure, she led strategic planning, capital raising activities, secured debt financing, and helped scale the business while strengthening its financial infrastructure and operating processes.

Previously, Ms. Hamill held senior level financial leadership roles at other leading CPG companies, including at WhiteWave Foods, which became part of Danone North America. At WhiteWave, she helped support ambitious growth strategies for premium brands such as Silk and SoDelicious.

Ms. Hamill will report to BARK’s Co-Founder, Executive Chairman, and Chief Executive Officer, Matt Meeker.

“Anya is an important addition to our leadership team as we continue to scale our business and strengthen BARK’s position as the world’s most dog-centric company,” said Mr. Meeker. “Her experience driving business performance at public and private companies, combined with her deep familiarity with consumer packaged goods across digital and retail channels, will be



exceptionally beneficial as we continue to grow and deliver value to all of our stockholders. We welcome Anya and her dog, Chachi, to BARK.”

Mr. Meeker added, “Brian Dostie, who has served as Interim Chief Financial Officer over the past year, will continue with the Company in his role as Vice President, Accounting and Controller. I want to thank Brian for his thoughtful leadership and meaningful contributions during this period. He has been, and will continue to be, a valuable partner to BARK.”

“As both a finance leader and a devoted dog person, I’m thrilled to join BARK,” said Ms. Hamill. “What drew me to the Company is its rare combination of a beloved brand, a deep data driven understanding of dogs and their people. I look forward to partnering with Matt and the team to build on BARK’s momentum, scale the business with discipline, and create lasting value for customers and stockholders.”

About BARK
BARK is the world’s most dog-centric company, devoted to making all dogs happy with the best products, services, and content. BARK’s dog-obsessed team leverages its unique, data-driven understanding of what makes each dog special to design playstyle-specific toys, wildly satisfying treats, and dog-first experiences that foster the health and happiness of dogs everywhere. Founded in 2011, BARK loyally serves millions of dogs nationwide with BarkBox and Super Chewer, its themed toys and treats subscriptions; custom product collections through its retail partner network, including Target, Chewy, and Amazon; and BARK Air, the first air travel experience designed specifically for dogs first. At BARK, we want to make dogs as happy as they make us because dogs and humans are better together. Sniff around at bark.co for more information.

Forward-Looking Statements
This press release contains forward-looking statements, including statements that are based on the Company’s current expectations, forecasts and assumptions and involve risks and uncertainties. In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “should,” “could,” “expect,” “plan,” "anticipate,” “believe,” “estimate,” “predict,” “intend,” “potential,” “continue,” “ongoing” or the negative of these terms or other comparable terminology. Actual results and outcomes could differ materially from any results or outcomes made or implied in such forward-looking statements. Important factors that could cause or contribute to such differences include, but are not limited to, risks and information included under the captions “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in the Company's annual report on Form 10-K for the year ended March 31, 2026, filed with the SEC on June 10, 2026, copies of which may be obtained by visiting the Company’s Investor Relations website at https://investors.bark.co/ or the SEC’s website at www.sec.gov. Undue reliance should not be placed on the forward-looking statements in this press release, which are based on information available to the Company on the date hereof. The Company assumes no obligation to update such statements except as required by law.




Contacts

Investors:
investors@barkbox.com
Media:
press@barkbox.com



Severance and Change in Control Agreement

This Severance and Change in Control Agreement (the “Agreement”) is entered into as of [DATE] (the “Effective Date”) by and between Anya Hamill (the “Executive” or “you”) and BARK, Inc., a Delaware corporation (the “Company”). Certain capitalized terms are defined in Section 7.

1.Terms of Agreement. Notwithstanding anything to the contrary contained in that certain Offer Letter by and between the Executive and the Company dated as of July 8, 2026 attached hereto as Exhibit A (the “Offer Letter”), this Agreement shall become effective as of the Effective Date and terminate upon the date that all obligations of the parties hereto with respect to this Agreement have been satisfied. To the extent that there are any conflicts between the terms of the Employment Agreements and this Agreement with respect to the subject matter of this Agreement, the terms of this Agreement shall apply and the Employment Agreement shall otherwise remain in full force and effect.

2. Term of Employment.

(a) Employment At Will. For the term of his or her employment under the Employment Agreement, (the Employment”), the Executive’s Employment with the Company shall be “at will,” meaning that either the Executive or the Company shall be entitled to terminate the Executive’s Employment at any time and for any reason, with or without Cause. Any contrary representations that may have been made to the Executive shall be superseded by this Agreement. This Agreement shall constitute the full and complete agreement between the Executive and the Company on the “at will” nature of the Executive’s Employment. Although Executive’s job duties, title, compensation and benefits, as well as the Company’s personnel policies and procedures, may change from time to time, the “at will” nature of the Executive’s employment may only be changed in an express written agreement signed by the Executive and a duly authorized officer of the Company (other than the Executive). The termination of the Executive’s Employment shall not limit or otherwise affect his or her obligations under Sections 4 and/or 5 below or his or her rights under Section 3 below.

(b) Rights Upon Termination. Except as expressly provided in Section 3 below, upon the termination of the Executive’s Employment, the Executive shall only be entitled to the compensation and benefits that the Executive has earned under this Agreement before the effective date of the termination. The payments under this Agreement shall fully discharge all responsibilities of the Company to the Executive (other than payments of accrued and vested executive benefits, if any, under the Company’s executive benefit plans).

3. Termination Benefits.

(a) General. If you are subject to an Involuntary Termination, then you will be entitled to the benefits described in Section 3(b). However, Section 3(b) will not apply unless you (i) have returned all Company property in your possession, and (ii) have executed a general release of all claims (with applicable carve-out for continued indemnification, non-disparagement and other customary exceptions) (the “Release”) that you may have against the Company or persons affiliated with the Company. You must execute and return the Release on or before the date specified by the Company in the prescribed form (the “Release Deadline”). The Release Deadline will in no event be later than fifty (50) days after your Separation. If you fail to return the Release on or before the



Release Deadline, or if you revoke the Release, then you will not be entitled to the benefits described in Section 3(b). Your obligation to provide the Release will be waived and treated as satisfied if the Company has not delivered the initial form of Release to you within ten (10) days after your employment ends. Further, Section 3(b) will not apply if you are terminated by the Company for your willful financial misconduct with respect to the Company, including, without limitation, the commission of an act of embezzlement or fraud or any other unauthorized use of corporate funds by you in which any such case was committed with the intent to result in your substantial personal enrichment.

(b) Severance Payments. If you are subject to an Involuntary Termination, then the Company will continue to pay you your then current base salary (the “Base Salary”) for twelve (12) months following your Separation (the “Severance Period”) and will pay your target annual bonus for the relevant fiscal year in which your Separation took place, which shall be paid in a lump sum at the time such annual bonus is paid to similarly situated executive employees at the Company, subject to execution of the Release provided for in Section 3(a). The salary continuation payments will commence on the first payroll date following expiration of the applicable revocation period of the Release provided for in Section 3(a) and thereafter on the Company’s normal payroll schedule. In the event you are subject to an Involuntary Termination in the six (6) months prior to a Change in Control, on a Change in Control or in the eighteen (18) months following a Change in Control, then the Company will pay you a lump sum cash payment equal to two (2) times the sum of (A) the Base Salary plus (B) your annual target bonus, subject to execution of the Release provided for in Section 3(a). However, if the fifty (50) day period described in Section 3(a) spans two (2) calendar years, then the salary continuation payments or, if applicable, the lump sum payment, will commence or be paid on the first payroll date following expiration of the applicable revocation period in the second calendar year. The Company’s obligation to make payments during the Severance Period will cease immediately upon your material breach of the PIIA (as defined below) after being provided written notice of such breach and thirty (30) days’ opportunity to cure.

(c) Equity Awards. If you are subject to an Involuntary Termination, then for the twelve (12) month period following your Separation, all of your outstanding and unvested option shares and equity awards that are subject to time-based vesting shall be 100% vested and non-forfeitable for such period. In the event you are subject to an Involuntary Termination in the six (6) months prior to a Change in Control, on a Change in Control or in the eighteen (18) months following a Change in Control, then all of your outstanding and unvested option shares and equity awards that are subject to time-based vesting shall be 100% vested and non-forfeitable.

(d) COBRA. If you are subject to an Involuntary Termination and you elect to continue your health insurance coverage under the Consolidated Omnibus Budget Reconciliation Act (“COBRA”) following your Separation, then the Company will continue pay the same percentage of your monthly premium under COBRA, which is understood to potentially be higher than said premium for active employees, for the twelve (12) months following your Separation (twenty-four (24) months if the Involuntary Termination is in connection with a Change in Control).

(e) Accrued Rights. You will be entitled to receive the following upon termination of employment for any reason: (i) accrued and unpaid Base Salary through the date of termination of employment; (ii) reimbursement for any unreimbursed business expenses; and (iii) such employee benefits, if any, to



which the Executive may be entitled under the applicable Company plans upon termination of employment.

4. Documents and Company Property. The Executive is prohibited from keeping in his or her possession in any way any correspondence, documents, other information carriers, copies thereof, and other goods made available by the Company or its affiliates to him or her (including, but not limited to, credit cards, mobile communication devices, keys, documents, handbooks, financial data, plans, USB sticks or other information carriers, access cards and laptop computer), except to the extent that this is necessary for the performance of his or her work for the Company. In any event, the Executive is obliged to immediately hand over such documents and other goods made available to him or her at the end of this Agreement or upon suspension of his or her active duties for any reason other than documents relating to his or her own employment and compensation.

5. Proprietary Information and Inventions Agreement. The Executive and the Company entered into that certain Proprietary Information and Inventions Assignment Agreement dated July 8, 2026 (the “PIIA”). The PIIA remains in full force and effect.

6. Successors.

(a) Company’s Successors. This Agreement shall be binding upon any successor (whether direct or indirect and whether by purchase, lease, merger, consolidation, liquidation or otherwise) to all or substantially all of the Company’s business and/or assets. For all purposes under this Agreement, the term Company” shall include any successor to the Company’s business and/or assets which becomes bound by this Agreement.

(b) Executive’s Successors. This Agreement and all rights of the Executive hereunder shall inure to the benefit of, and be enforceable by, the Executive’s personal or legal representatives, executors, administrators, successors, heirs, distributees, devisees and legatees.

7. Definitions. The following terms shall have the meaning set forth below wherever they are used in this Agreement:

(a) Cause. The term “Cause shall mean:

(i)    your willful and substantial failure or neglect to follow the lawful directions of the Board which, if reasonably susceptible of cure, is not cured within fifteen (15) days after written notice to you specifying the failure or neglect;
(ii)    your intentional disloyalty, gross negligence, willful misconduct, dishonesty or breach of fiduciary duty to the Company;
(iii)    the commission by you of an act of embezzlement or fraud or any other unauthorized use of corporate funds in which any such case was committed with the intent to result in your substantial personal enrichment;
(iv)    your deliberate disregard of the written rules or policies of the Company which results in direct or indirect loss, damage or injury to the Company which is material to the Company; or
(v)    the unauthorized disclosure by you of any trade secret or confidential information of the Company that results in material harm to the Company.




(b) Change in Control. The term “Change in Control” shall mean (i) any “person” (as such term is used in Sections 13(d) and 14(d) of the Exchange Act) becomes the “beneficial owner (as defined in Rule 13d-3 of the Exchange Act), directly or indirectly, of securities of the Company representing more than fifty percent (50%) of the total voting power represented by the Company’s then-outstanding voting securities; (ii) the consummation of a merger or consolidation of the Company with or into any other entity, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity or its parent) more than fifty percent (50%) of the total voting power represented by the voting securities of the Company or such surviving entity or its parent outstanding immediately after such merger or consolidation; or (iii) the sale, transfer or other disposition of all or substantially all of the Company’s assets.

(c) Code. The term “Code” shall mean the Internal Revenue Code of 1986, as amended.

(d) Disability. The term “Disability” shall mean that the Executive is unable to engage in any substantial gainful activity as required to perform his or her material duties (with reasonable accommodation) by reason of any medically determinable physical or mental impairment which can be expected to result in death or to last for a continuous period of not less than twelve months.

(e) Involuntary Termination. The term “Involuntary Termination shall mean either the Executive’s (i) Termination Without Cause or (ii) Resignation for Good Reason.

(f) Resignation for Good Reason. The term “Resignation for Good Reason” means a Separation as a result of the Executive’s resignation within 12 months after one of the following conditions has come into existence without the Executive’s written consent:

(i) a decrease (in one or a series of reductions) in the Base Salary of 10% or greater;
(ii) a material diminution in the Executive’s duties, responsibilities and authorities, or any other action by the Company which results in a material diminution in such authority, duties or responsibilities;
(iii) the relocation of the Executive’s work place to a location greater than thirty-five (35) miles from the Executive’s then-existing primary place of business; or
(iv) a material breach of the Company’s obligations under this Agreement, as may be amended from time to time, or any other written agreement between the Executive and the Company.

(g) A Resignation for Good Reason shall not be deemed to have occurred unless the Executive gives the Company written notice of the condition within ninety (90) days after the condition comes into existence and the Company fails to remedy the condition within fifteen (15) days after receiving the Executive’s written notice and the Executive resigns no later than thirty (30) days following the Company’s failure to remedy the condition giving rise to such Resignation for Good Reason.

(h) Separation. The term “Separation shall mean a “separation from service,” as defined in the regulations under Section 409A of the Code.




(i) Termination Without Cause. The term “Termination Without Cause means a Separation as a result of a termination of the Executive’s employment by the Company without Cause and other than as a result of Disability.

8. Miscellaneous Provisions.

(a) Notice. Notices and all other communications contemplated by this Agreement shall be in writing and shall be deemed to have been duly given when personally delivered, when delivered via email to a Company domain email address or, following the Separation, to the Executive’s personal email address on file with Human Resources, when delivered by FedEx with delivery charges prepaid, or when mailed by U.S. registered or certified mail, return receipt requested and postage prepaid. In the case of the Executive, mailed notices shall be addressed to him or her at the home address that he or she most recently communicated to the Company in writing. In the case of the Company, mailed notices shall be addressed to its corporate headquarters, and all notices shall be directed to the attention of its Secretary.

(b) Modifications and Waivers. No provision of this Agreement shall be modified, waived or discharged unless the modification, waiver or discharge is agreed to in writing and signed by the Executive and by an authorized officer of the Company (other than the Executive). No waiver by either party of any breach of, or of compliance with, any condition or provision of this Agreement by the other party shall be considered a waiver of any other condition or provision or of the same condition or provision at another time.

(c) Whole Agreement. This Agreement supersedes and replaces any prior agreements, representations or understandings (whether written, oral, implied or otherwise) between the Executive and the Company and constitute the complete agreement between the Executive and the Company regarding the subject matter set forth herein.

(d) Tax Matters. All payments made under this Agreement shall be subject to reduction to reflect taxes or other charges required to be withheld by law. The Company intends that all payments and benefits provided under this Agreement or otherwise are exempt from, or comply with, with the requirements of Code Section 409A so that none of the payments or benefits will be subject to the additional tax imposed under Code Section 409A, and any ambiguities herein will be interpreted in accordance with such intent. For purposes of Code Section 409A, each payment, installment or benefit payable under this Agreement is hereby designated as a separate payment. In addition, if the Company determines that you are a “specified Executive” under Code Section 409A(a)(2)(B)(i) at the time of your Separation, then (i) any severance payments or benefits, to the extent that they are subject to Code Section 409A, will not be paid or otherwise provided until the first business day following (A) expiration of the six-month period measured from your Separation or (B) the date of your death and (ii) any installments that otherwise would have been paid or provided prior to such date will be paid or provided in a lump sum when the severance payments or benefits commence. The Company shall not have a duty to design its compensation policies in a manner that minimizes your tax liabilities, and you agree not to make any claim against the Company or the Board related to tax liabilities arising from your compensation.

(e) 280G Parachute Payments. If any payment or benefit that you would receive in connection with a Change in Control from the Company or otherwise (“Payment”) would (i) constitute a “parachute



payment within the meaning of Section 280G of the Code, and (ii) but for this sentence, be subject to the excise tax imposed by Section 4999 of the Code (the “Excise Tax”), then such Payment shall be equal to the Reduced Amount. The “Reduced Amount” shall be either (x) the largest portion of the Payment that would result in no portion of the Payment being subject to the Excise Tax, or (y) the largest portion, up to and including the total, of the Payment, whichever amount, after taking into account all applicable federal, state and local employment taxes, income taxes, and the Excise Tax (all computed at the highest applicable marginal rate), results in your receipt of the greatest economic benefit notwithstanding that all or some portion of the Payment may be subject to the Excise Tax. If a reduction in payments or benefits constituting “parachute payments” is necessary so that the Payment equals the Reduced Amount, any reduction shall be applied first, on a pro rata basis, to amounts that constitute deferred compensation within the meaning of Section 409A of the Code, and, in the event that the reductions pursuant to this Section 8(e) exceed payments that are subject to Section 409A of the Code, the remaining reductions shall be applied, on a pro rata basis, to any other remaining payments, first with respect to amounts payable in cash before being made in respect to any payments to be provided in the form of benefits or equity award acceleration, and in the form of benefits before being made with respect to equity award acceleration. The Company’s determinations hereunder shall be final, binding and conclusive on all interested parties.

(f) Arbitration. Any controversy or claim arising out of this Agreement and any and all claims relating to your employment with the Company will be settled by final and binding arbitration. The arbitration will take place in the State of New York. The arbitration will be administered by the American Arbitration Association under its National Rules for the Resolution of Employment Disputes. Any award or finding will be confidential. You and the Company agree to provide one another with reasonable access to documents and witnesses in connection with the resolution of the dispute. You and the Company will share the costs of arbitration equally up to, for you, the filing fee to bring a civil action in the state courts of New York. Each party will be responsible for its own attorneys’ fees, and the arbitrator may not award attorneys’ fees unless a statute or contract at issue specifically authorizes such an award. This Section 8(f) does not apply to claims for workers’ compensation benefits or unemployment insurance benefits. This Section 8(f) also does not apply to claims concerning the ownership, validity, infringement, misappropriation, disclosure, misuse or enforceability of any confidential information, patent right, copyright, mask work, trademark or any other trade secret or intellectual property held or sought by either you or the Company (whether or not arising under the PIIA).

(g) Choice of Law and Severability. This Agreement shall be interpreted in accordance with the laws of the State of New York (except its provisions governing the choice of law). If any provision of this Agreement becomes or is deemed invalid, illegal or unenforceable in any applicable jurisdiction by reason of the scope, extent or duration of its coverage or any other reason, then such provision shall be deemed amended to the minimum extent necessary to conform to applicable law so as to be valid and enforceable or, if such provision cannot be so amended without materially altering the intention of the parties, then such provision shall be stricken and the remainder of this Agreement shall continue in full force and effect. If any provision of this Agreement is rendered illegal by any present or future statute, law, ordinance or regulation (collectively the “Law”), then such provision shall be curtailed or limited only to the minimum extent necessary to bring such provision into compliance with the Law. All the other terms and provisions of this Agreement shall continue in full force and effect without impairment or limitation.




(h) No Assignment. This Agreement and all rights and obligations of the Executive hereunder are personal to the Executive and may not be transferred or assigned by the Executive at any time. The Company may assign its rights under this Agreement to any entity that assumes the Company’s obligations hereunder in connection with any sale or transfer of all or a substantial portion of the Company’s assets to such entity.

(i) Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.

IN WITNESS WHEREOF, each of the parties has executed this Agreement, in the case of the Company by its duly authorized officer, as of the day and year first above written.


                BARK, Inc.


Signature: _________________________________

Title: _____________________________________

Date: _____________________________________


Executive
Signature: _________________________________

Date:         

Exhibit A: Offer Letter








Filing Exhibits & Attachments

6 documents